Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma
NCT04042805
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Interventions
BIOLOGICAL:
Sintilimab
DRUG:
Lenvatinib
Sponsor
Baocai Xing